INS and Neonatal hypoglycemia: Risk for any neonatal hypoglycemia still remained significantly higher with glyburide compared to insulin [RR, 2.29; 95%CI, 1.49 to 3.54; p = 0.0002], with I2 decreased from 41% to 13%.